Towa Pharmaceutical Co Ltd
F:6QC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Towa Pharmaceutical Co Ltd
F:6QC
|
JP |
|
S
|
SaveLend Group AB
STO:YIELD
|
SE |
|
I
|
Ibc Advanced Alloys Corp
OTC:IAALF
|
US |
|
Portmeirion Group PLC
OTC:POTMF
|
UK |
|
Bewi ASA
F:5T0
|
NO |
|
Spey Resources Corp
F:2JS
|
CA |
|
O
|
Oaktree Specialty Lending Corp
F:FFC
|
US |
|
C
|
Cts Eventim AG & Co KgaA
XMUN:EVD
|
DE |
|
Corporacion Financiera Alba SA
F:CSV
|
ES |
|
Ondeck Co Ltd
TSE:7360
|
JP |
|
Da-Li Development Co Ltd
TWSE:6177
|
TW |
|
Wiremedia Inc
OTC:WRMA
|
US |
|
K
|
Kamanwala Housing Construction Ltd
BSE:511131
|
IN |
|
S
|
Slam Corp
NASDAQ:SLAM
|
US |
|
iSelect Ltd
ASX:ISU
|
AU |
|
Blue Earth Resources Inc
OTC:BERI
|
US |
|
H
|
Hoa An JSC
VN:DHA
|
VN |
|
Tingo Group Inc
OTC:TIOG
|
US |
|
Oscar Properties Holding AB
STO:OP
|
SE |
|
Newport Exploration Ltd
XTSX:NWX
|
CA |
|
T
|
Thantawan Industry PCL
SET:THIP
|
TH |
|
K
|
KSE Ltd
BSE:519421
|
IN |
|
S
|
Super Energy Corporation PCL
SET:SUPER
|
TH |
Wall St Price Targets
6QC Price Targets Summary
Towa Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for 6QC is 21.71 EUR with a low forecast of 18.37 EUR and a high forecast of 25.03 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6QC's stock price target?
Price Target
21.71
EUR
According to Wall Street analysts, the average 1-year price target for 6QC is 21.71 EUR with a low forecast of 18.37 EUR and a high forecast of 25.03 EUR.
What is the Revenue forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 2 years is 8%.
What is the Pre-Tax Income forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 2 years is 44%.
What is the Net Income forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
100%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 2 years is 100%.
